Document is current
Any future updates will be listed below
-
Authors
Davis, S. Lindsey https://orcid.org/0000-0003-3899-9481
Hartman, Sarah J.
Bagby, Stacey M.
Schlaepfer, Marina
Yacob, Betelehem W.
Tse, Tonia
Simmons, Dennis M.
Diamond, Jennifer R.
Lieu, Christopher H.
Leal, Alexis D.
Cadogan, Elaine B.
Hughes, Gareth D.
Durant, Stephen T.
Messersmith, Wells A.
Pitts, Todd M.
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 4 June 2021
Accepted: 11 September 2022
First Online: 29 October 2022
Declarations
:
: Animal studies were performed in a facility accredited by the American Association for Accreditation of Laboratory Animal Care in accordance with NIH guidelines and approved by the University of Colorado Institutional Animal Care and Use Committee prior to initiation (IACUC number 021).
: Not applicable.
: SLD served as a local Principal Investigator on the AZ AToM clinical trial (NCT02588105), with funding support provided to the University of Colorado Cancer Center for these efforts. TP received grant funding from AstraZeneca for this project. EC, GH, and SD are employees of AstraZeneca.
